Evidence map›Paper›PMID 29929980›Full record

ArticleThe Journal of biological chemistry2018

An

Jeremy S Morris, Ryan A Groves, Jillian M Hagel, Peter J Facchini

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Effects of congeners of amphetamine on the human heart.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Interpol review of controlled substances 2016-2019.Forensic science international. Synergy · 2020
    Review
  9. Structure-function studies of tetrahydroprotoberberineThe Journal of biological chemistry · 2019
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jeremy S MorrisFrom the Department of Biological Sciences, University of Calgary, Calgary, Alberta T2N 1N4, Canada.
Ryan A GrovesFrom the Department of Biological Sciences, University of Calgary, Calgary, Alberta T2N 1N4, Canada.
Jillian M HagelFrom the Department of Biological Sciences, University of Calgary, Calgary, Alberta T2N 1N4, Canada.
Peter J FacchiniFrom the Department of Biological Sciences, University of Calgary, Calgary, Alberta T2N 1N4, Canada pfacchin@ucalgary.ca.
University of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phenylalkylamines, such as the plant compounds ephedrine and pseudoephedrine and the animal neurotransmitters dopamine and adrenaline, compose a large class of natural and synthetic molecules with important physiological functions and pharmaceutically valuable bioactivities. The final steps of ephedrine and pseudoephedrine biosynthesis in members of the plant genus

Indexed as

Biosynthetic PathwaysEphedra sinicaEphedrineMethyltransferasesPseudoephedrineSecondary MetabolismSubstrate SpecificityTranscriptomeEphedrineMethyltransferasesPseudoephedrinebiochemical genomicsEphedra sinicagenomicsnatural productN-methyltransferaseplant biochemistryplant molecular biologysecondary metabolismsecondary metabolitesubstituted phenylalkylaminesynthetic biology

Identifiers

PMID29929980
PMCPMC6120201
OpenAlexW2808895738

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.